Author： Johnson Melissa D Perfect John R
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.5, 2003-05, pp. : 807-823
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets, Vol. 15, Iss. 2, 2014-02 ,pp. :
Access to resources
Recommend
Lifibrol: first member of a new class of
By Scharnagl H. Mrz W. Wieland H.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. :
Caspofungin - a novel antifungal agent for systemic infections
Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. :